SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report: August 23, 2000
ALLIED HEALTHCARE PRODUCTS, INC.
(Exact Name of Registrant as Specified in Charter)
Delaware 0-19266 23-1370721
(State or Other (Commission (IRS Employer
Jurisdiction of File Number) Identification No.)
Incorporation)
1720 Sublette Avenue
St. Louis, MO 63110
(Address of Principal Executive Offices) (Zip Code)
(314) 771-2400
(Registrant's telephone number, including area code)
page 1 of 5
<PAGE>
ITEM 5. OTHER EVENTS.
On August 23, 2000, the Registrant issued a news release that is has named
Gregory C. Kowert, vice president-finance, chief financial officer and
secretary. Mr. Kowert replaces Thomas A. Jenuleson, CFO since March 1999, who
has resigned to pursue other interests. The news release is attached as Exhibit
1 hereto, is incorporated herein by reference and made a part hereof.
page 2 of 5
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
ALLIED HEALTHCARE PRODUCTS, INC.
Date: August 23, 2000 By: /s/ Earl R. Refsland
-----------------------------
Name: Earl R. Refsland
Title: President and Chief Executive Officer
Page 3 of 5
<PAGE>
EXHIBIT INDEX
Exhibit No. Description Page No.
----------- ----------- --------
1. News Release dated August 23, 2000 5
page 4 of 5
<PAGE>
